Home
Resources
Publications
Huperzine A: A Promising Anticonvulsant, Disease Modifying, and Memory Enhancing Treatment Option in Alzheimer's Disease

Huperzine A: A Promising Anticonvulsant, Disease Modifying, and Memory Enhancing Treatment Option in Alzheimer's Disease

Ugur Damar, Roman Gersner, Joshua T Johnstone, Steven Schachter, Alexander Rotenberg

Med Hypotheses. 2017 Feb;99:57-62.

PMID: 28110700

Abstract:

Alzheimer's disease (AD) is the most frequent cause of dementia. Besides cognitive deterioration, patients with AD are prone to seizures - more than 20% of patients diagnosed with AD experience at least one unprovoked seizure and up to 7% have recurrent seizures. Although available antiepileptic drugs (AEDs) may suppress seizures in patients with AD, they may also worsen cognitive dysfunction and increase the risk of falls. On the basis of preclinical studies, we hypothesize that Huperzine A (HupA), a safe and potent acetylcholinesterase (AChE) inhibitor with potentially disease-modifying qualities in AD, may have a realistic role as an anticonvulsant in AD.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP102518796-B	Huperzine A		102518-79-6	Price
AP120786187	(±)-Huperzine A		120786-18-7	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: